VERACYTE, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
VERACYTE, INC. (VCYT) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$30.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- VERACYTE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2021-03-31 was -$3.50M.
- VERACYTE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$30.70M, a 134.85% decline from fiscal 2024.
- VERACYTE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $88.10M, a 507.59% increase from fiscal 2023.
- VERACYTE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $14.50M, a 202.08% increase from fiscal 2022.
- VERACYTE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $4.80M, a 88.54% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|---|
| 2025-12-31 | -$30.70M 10-K · filed 2026-02-26 | ||
| 2024-12-31 | $88.10M 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $14.50M 10-K · filed 2026-02-26 | ||
| 2022-12-31 | $4.80M 10-K · filed 2025-02-28 | ||
| 2021-12-31 | $41.90M 10-K · filed 2024-02-29 | ||
| 2021-03-31 | -$3.50M 10-Q · filed 2021-05-10 | ||
| 2021-03-12 | -$3.50M 10-Q · filed 2021-07-29 | ||
| 2020-12-31 | $13.40M 10-K · filed 2023-03-01 | ||
| 2019-12-31 | $9.90M 10-K · filed 2022-02-28 | ||
| 2018-12-31 | $3.70M 10-K · filed 2021-02-22 | ||
| 2017-12-31 | -$14.30M 10-K · filed 2020-02-25 | ||
| 2016-12-31 | $10.90M 10-K · filed 2019-02-25 | ||
| 2015-12-31 | $11.70M 10-K · filed 2018-02-27 | ||
| 2014-12-31 | $10.60M 10-K · filed 2017-03-01 | ||
| 2013-12-31 | $8.10M 10-K · filed 2016-03-14 | ||
| 2012-12-31 | $7.30M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |